TABLE 3: Protective effect of carvacrol against parathion treated cultured human peripheral blood lymphocytes
. Treatments Concentrations Metaphase used scored ([micro]g/mL + SCE/cell [+ or -]SE [micro]g/mL) Control Untreated 50 2.46[+ or -]0.16 Parathlon 2.5 50 5.63[+ or -]0.52 (a) Parathlon + carvacrol 2.5 + 2.5 50 4.33[+ or -]0.12 (b) Parathlon + carvacrol 2.5 + 5.0 50 3.07[+ or -]0.14 (b) Carvacrol 2.5 50 2.56[+ or -]0.19 (c) Carvacrol 5.0 50 2.86[+ or -]0.21 (c) DMSO (-ve control) 20 50 2.32[+ or -]0.17 (d) (a) P < 0.05 (significance as compared to untreated), (b) P < 0.05 (significant as compared to parathion treatment), (c) P > 0.05 (nonsignificance as compared to untreated), and (c) P > 0.05 (nonsignificance as compared to untreated).
The aim of this study was to evaluate the exposure of a variety of doses of [As.sub.2][O.sub.3] upon human peripheral blood lymphocytes
and the likely favorable consequence of kalmegh upon arsenic-induced genotoxieity.
In a recent report involving alcoholics and controls (2), pharmacokinetic parameters for CZX hydroxylation (CZX clearance rate and CZX AUC) were compared with CYP2E1 protein and mRNA content in human peripheral blood lymphocytes
Metallothionein 1 isoform gene expression induced by cadmium in human peripheral blood lymphocytes
. Biomed Environ Sci 19:104-109.
Simple method for comparing large numbers of flow cytometry histograms exemplified by analysis of the CD4 ([T.sub.4]) antigen and LDL receptor on human peripheral blood lymphocytes
. J Histochem Cytochem 1986;34:1217-21.
In the first step, primers T7CYP2E1 (5'-TAATACGACTCACTATAGGACAGGGA-CAGGGGAATCAT-3') and recRNA (5'-TGGGGTCCAGAGATTGATGCAGGCAAGTAGTGTAGAAAG-3') were used to amplify a cDNA from human peripheral blood lymphocytes
. Primer T7CYP2E1 contains the T7 promoter sequence at the 5'-end of primer CYP2E1F (underlined sequence), and primer recRNA corresponds to CYP2E1R with the exception of a mismatching stretch of 20 bp located at the 3'-end (underlined sequence).
Activation-induced cell death in human peripheral blood lymphocytes
after stimulation with silicate in vitro.